Biomarin Pharmaceutical Inc (BMRN) — Net Asset Quality Index
Biomarin Pharmaceutical Inc (BMRN) has a Net Asset Quality Index of 53.9% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $11.72 Billion minus total liabilities of $5.40 Billion yields net assets of $6.32 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Read BMRN liabilities breakdown for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Biomarin Pharmaceutical Inc Net Asset Quality Index Over Time (1998–2025)
This chart shows how Biomarin Pharmaceutical Inc's Net Asset Quality Index has evolved across 28 annual periods from 1998 to 2025. As of June 2026, the index stands at 53.9%, representing net assets of $6.32 Billion against total assets of $11.72 Billion USD. For live market cap and overall valuation, see Biomarin Pharmaceutical Inc (BMRN) market capitalisation.
Annual Net Asset Quality Index for Biomarin Pharmaceutical Inc (1998–2025)
The table below presents the year-by-year Net Asset Quality Index for Biomarin Pharmaceutical Inc from 1998 to 2025, covering 28 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check Biomarin Pharmaceutical Inc strategic asset allocation index to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 80.2% | $6.09 Billion | $7.59 Billion | $1.51 Billion | ▼ -0.8 pp |
| 2024 | 81.0% | $5.66 Billion | $6.99 Billion | $1.33 Billion | ▲ +8.6 pp |
| 2023 | 72.4% | $4.95 Billion | $6.84 Billion | $1.89 Billion | ▲ +0.2 pp |
| 2022 | 72.2% | $4.60 Billion | $6.38 Billion | $1.77 Billion | ▲ +1.1 pp |
| 2021 | 71.1% | $4.27 Billion | $6.00 Billion | $1.73 Billion | ▲ +0.9 pp |
| 2020 | 70.2% | $4.11 Billion | $5.85 Billion | $1.74 Billion | ▲ +3.6 pp |
| 2019 | 66.6% | $3.12 Billion | $4.69 Billion | $1.57 Billion | ▼ -0.5 pp |
| 2018 | 67.0% | $2.97 Billion | $4.43 Billion | $1.46 Billion | ▲ +6.4 pp |
| 2017 | 60.6% | $2.81 Billion | $4.63 Billion | $1.82 Billion | ▼ -8.1 pp |
| 2016 | 68.7% | $2.77 Billion | $4.02 Billion | $1.26 Billion | ▲ +4.4 pp |
| 2015 | 64.4% | $2.40 Billion | $3.73 Billion | $1.33 Billion | ▲ +3.0 pp |
| 2014 | 61.4% | $1.53 Billion | $2.49 Billion | $962.56 Million | ▲ +1.6 pp |
| 2013 | 59.8% | $1.34 Billion | $2.24 Billion | $903.02 Million | ▼ -5.0 pp |
| 2012 | 64.8% | $1.02 Billion | $1.57 Billion | $552.58 Million | ▲ +5.6 pp |
| 2011 | 59.2% | $773.05 Million | $1.31 Billion | $532.66 Million | ▲ +2.4 pp |
| 2010 | 56.8% | $717.26 Million | $1.26 Billion | $545.37 Million | ▲ +21.7 pp |
| 2009 | 35.1% | $322.19 Million | $917.16 Million | $594.98 Million | ▲ +4.6 pp |
| 2008 | 30.5% | $276.68 Million | $906.70 Million | $630.02 Million | ▲ +7.5 pp |
| 2007 | 23.0% | $187.73 Million | $815.28 Million | $627.55 Million | ▼ -2.4 pp |
| 2006 | 25.4% | $117.80 Million | $463.44 Million | $345.63 Million | ▲ +65.1 pp |
| 2005 | -39.7% | $-77.46 Million | $195.30 Million | $272.76 Million | ▼ -10.5 pp |
| 2004 | -29.2% | $-67.98 Million | $232.97 Million | $300.94 Million | ▼ -75.2 pp |
| 2003 | 46.0% | $117.85 Million | $256.34 Million | $138.49 Million | ▼ -43.1 pp |
| 2002 | 89.1% | $98.54 Million | $110.62 Million | $12.07 Million | ▼ -3.8 pp |
| 2001 | 92.9% | $159.55 Million | $171.81 Million | $12.26 Million | ▲ +1.9 pp |
| 2000 | 91.0% | $69.99 Million | $76.93 Million | $6.94 Million | ▼ -4.0 pp |
| 1999 | 95.0% | $98.38 Million | $103.55 Million | $5.17 Million | ▲ +1.7 pp |
| 1998 | 93.3% | $29.40 Million | $31.51 Million | $2.11 Million | — |